Autologous Mesenchymal Stromal Cell Infusion As Adjunct Treatment In Patients With Multidrug And Extensively Drug-resistant Tuberculosis: An Open-label Phase 1 Safety Trial
Aliaksandr Skrahin, Raija K Ahmed, Giovanni Ferrara, Lalit Rane, Thomas Poiret, Yanina Isaikina, Alena Skrahina, Alimuddin Zumla, Markus J Maeurer
Twitter
Facebook
LinkedIn
Email